3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde

C16H21N7O2 — CID 175887588

IUPAC3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde
SMILESCc1cc(Nc2cc(CO)nc(N3CC4CCC(C3)N4C=O)n2)n[nH]1
InChIInChI=1S/C16H21N7O2/c1-10-4-15(21-20-10)18-14-5-11(8-24)17-16(19-14)22-6-12-2-3-13(7-22)23(12)9-25/h4-5,9,12-13,24H,2-3,6-8H2,1H3,(H2,17,18,19,20,21)
InChIKeyMQUNVTIBJGHSOM-UHFFFAOYSA-N
MW343.39 g/mol
LogP0.55
Rot. Bonds5

About 3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde

3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde (PubChem CID 175887588) has the molecular formula C16H21N7O2 and a molecular weight of 343.39 g/mol. Its IUPAC name is 3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde.

Molecular Properties

Compound Name3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde
PubChem CID175887588
Molecular FormulaC16H21N7O2
Molecular Weight343.39 g/mol
Exact Mass343.18
IUPAC Name3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde
SMILESCc1cc(Nc2cc(CO)nc(N3CC4CCC(C3)N4C=O)n2)n[nH]1
InChIInChI=1S/C16H21N7O2/c1-10-4-15(21-20-10)18-14-5-11(8-24)17-16(19-14)22-6-12-2-3-13(7-22)23(12)9-25/h4-5,9,12-13,24H,2-3,6-8H2,1H3,(H2,17,18,19,20,21)
InChIKeyMQUNVTIBJGHSOM-UHFFFAOYSA-N
XLogP0.55
TPSA110.27 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500343.39
LogP ≤ 50.55
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze 3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde?
The IUPAC name of 3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde (CID 175887588) is 3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde.
What is the SMILES notation for 3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde?
The canonical SMILES for 3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde is Cc1cc(Nc2cc(CO)nc(N3CC4CCC(C3)N4C=O)n2)n[nH]1.
What is the InChIKey of 3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde?
The InChIKey is MQUNVTIBJGHSOM-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H21N7O2/c1-10-4-15(21-20-10)18-14-5-11(8-24)17-16(19-14)22-6-12-2-3-13(7-22)23(12)9-25/h4-5,9,12-13,24H,2-3,6-8H2,1H3,(H2,17,18,19,20,21).
What are the key properties of 3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde?
3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde has a molecular weight of 343.39 g/mol, XLogP of 0.55, 5 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-(hydroxymethyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]-3,8-diazabicyclo[3.2.1]octane-8-carbaldehyde is sourced from PubChem (CID 175887588), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).